8
Oct
2024

SYNVIA

Exhibitor at CPHI Milan 2024 stand 14D40, Finished Dosage Formulations
About Us

Synvia, is a Brazilian company with 20 years of experience facilitating access to global pharmaceutical market and providing cost-effective solutions for clinical trials.

We have extensive experience in Bioequivalence studies (PK/PD) and clinical trials Phase I-IV. Through our full-service CRO, we offer a comprehensive suite of services.

Our clinical units and bioanalytical laboratory are co-located, simplifying processes by eliminating the need for sample transportation. Furthermore, Synvia is home to one of the largest analytical parks in Latin America.

  • BR
  • 2024
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Biopharmaceutical company
Consultancy
Contract Research Organisation (CRO)
Contract Service
Primary activities
Analytical Services
Biopharmaceutical
Clinical Research
Contract Research Organisation
Laboratory Services
Regulatory Affairs
Contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 14D40, Finished Dosage Formulations